{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:48:39Z","timestamp":1792759719989,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T00:00:00Z","timestamp":1653696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contactlensjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contact Lens and Anterior Eye"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.clae.2022.101723","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:41:56Z","timestamp":1653957716000},"page":"101723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trial"],"prefix":"10.1016","volume":"46","author":[{"given":"Qi","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex LK","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George PM","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor CP","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clae.2022.101723_b0005","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/IAE.0000000000002590","article-title":"Prevalence and time trends of myopia in children and adolescents in China : a systemic review and meta-analysis","volume":"40","author":"Dong","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.clae.2022.101723_b0010","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/archophthalmol.2011.230","article-title":"Prevalence and characteristics of myopic retinopathy in a rural Chinese adult population: the Handan Eye Study","volume":"129","author":"Gao","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2022.101723_b0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ophtha.2015.07.002","article-title":"The association of refractive error with glaucoma in a multiethnic population","volume":"123","author":"Shen","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clae.2022.101723_b0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/IAE.0000000000001908","article-title":"Impact of etiology on the outcome of pediatric rhegamtogenous retinal detachement","volume":"39","author":"Huang","year":"2019","journal-title":"Retina"},{"issue":"9","key":"10.1016\/j.clae.2022.101723_b0025","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1097\/IAE.0000000000002238","article-title":"Pediatric retinal detachment in an Asian population with high prevalence of myopia: clinical characteristics, surgical outcomes, and prognostic factors","volume":"39","author":"Tsai","year":"2019","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.clae.2022.101723_b0030","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","article-title":"Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis","volume":"123","author":"Huang","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clae.2022.101723_b0035","doi-asserted-by":"crossref","first-page":"M106","DOI":"10.1167\/iovs.18-25958","article-title":"IMI - Interventions Myopia Institute: Interventions for Controlling Myopia Onset and Progression Report","volume":"60","author":"Wildsoet","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.clae.2022.101723_b0040","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","article-title":"Atropine for the treatment of childhood myopia","volume":"113","author":"Chua","year":"2006","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.clae.2022.101723_b0045","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.clae.2022.101723_b0050","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ophtha.2008.10.020","article-title":"Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine","volume":"116","author":"Tong","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clae.2022.101723_b0055","doi-asserted-by":"crossref","unstructured":"Chia A, Chua WH, Wen L, Fong A, Goon YY, Tan D. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%. Am J Ophthalmol 2014;157: 451-7 e451.","DOI":"10.1016\/j.ajo.2013.09.020"},{"issue":"1","key":"10.1016\/j.clae.2022.101723_b0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-Concentration Atropine for Myopia Progression (LAMP) Study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clae.2022.101723_b0065","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1167\/iovs.13-12527","article-title":"Myopia control using toric orthokeratology (TO-SEE study)","volume":"54","author":"Chen","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clae.2022.101723_b0070","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1167\/iovs.12-10565","article-title":"Retardation of myopia in orthokeratology (ROMIO) study: a 2-year randomized clinical trial","volume":"53","author":"Cho","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clae.2022.101723_b0075","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/OPX.0b013e318293657d","article-title":"High myopia-partial reduction ortho-k: a 2-year randomized study","volume":"90","author":"Charm","year":"2013","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.clae.2022.101723_b0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1471-2415-14-141","article-title":"The control effect of orthokeratology on axial length elongation in Chinese children with myopia","volume":"14","author":"Zhu","year":"2014","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.clae.2022.101723_b0085","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1167\/iovs.11-8005","article-title":"Myopia control with orthokeratology contact lenses in Spain: refractive and biometric changes","volume":"53","author":"Santodomingo-Rubido","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clae.2022.101723_b0090","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1167\/iovs.11-8453","article-title":"Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia: a 5-year follow-up study","volume":"53","author":"Hiraoka","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.clae.2022.101723_b0095","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/bjo.2008.151365","article-title":"Corneal reshaping and myopia progression","volume":"93","author":"Walline","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clae.2022.101723_b0100","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1167\/iovs.12-9943","article-title":"Muscarinic antagonist control of myopia: evidence for M4 and M1 receptor-based pathways in the inhibition of experimentally-induced axial myopia in the tree shrew selective muscarinic antagonist control of myopia","volume":"53","author":"Arumugam","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clae.2022.101723_b0105","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1475-1313.2011.00841.x","article-title":"The M4 muscarinic antagonist MT-3 inhibits myopia in chick: evidence for site of action","volume":"31","author":"McBrien","year":"2011","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.clae.2022.101723_b0110","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1167\/iovs.10-5716","article-title":"The effect of two-zone concentric bifocal spectacle lenses on refractive error development and eye growth in young chicks","volume":"52","author":"Liu","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clae.2022.101723_b0115","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1167\/iovs.12-9628","article-title":"The effective add inherent in 2-zone negative lenses inhibits eye growth in myopic young chicks","volume":"53","author":"Liu","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clae.2022.101723_b0120","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","article-title":"Two-year clinical trial of the Low-Concentration Atropine for Myopia Progression (LAMP) study: phase 2 report","volume":"127","author":"Yam","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clae.2022.101723_b0125","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","article-title":"Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops","volume":"123","author":"Chia","year":"2016","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.clae.2022.101723_b0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69710-8","article-title":"Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial","volume":"10","author":"Kinoshita","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.clae.2022.101723_b0135","doi-asserted-by":"crossref","DOI":"10.1136\/bjophthalmol-2020-317980","article-title":"Two-year add-on effect of using low concentration atropine in poor responders of orthokeratology in myopic children","author":"Chen","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clae.2022.101723_b0140","doi-asserted-by":"crossref","unstructured":"Zhao W, Li Z, Hu Y, Jiang J, Long W, Cui D et al. Short-term effects of atropine combined with orthokeratology (ACO) on choroidal thickness. Cont Lens Anterior Eye 2021;44:101348.","DOI":"10.1016\/j.clae.2020.06.006"},{"issue":"5","key":"10.1016\/j.clae.2022.101723_b0145","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/opo.12722","article-title":"One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial","volume":"40","author":"Tan","year":"2020","journal-title":"Ophthalmic Physiol Opt"},{"issue":"6","key":"10.1016\/j.clae.2022.101723_b0150","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/02713683.2019.1568501","article-title":"Combined Atropine with Orthokeratology for Myopia Control: Study Design and Preliminary Results","volume":"44","author":"Tan","year":"2019","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.clae.2022.101723_b0155","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1167\/iovs.11-7364","article-title":"Diurnal variations in axial length, choroidal thickness, intraocular pressure, and ocular biometrics","volume":"52","author":"Chakraborty","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clae.2022.101723_b0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1167\/iovs.11-8782","article-title":"Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography","volume":"53","author":"Tan","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.clae.2022.101723_b0165","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/iovs.08-1779","article-title":"In vivo human choroidal thickness measurements: evidence for diurnal fluctuations","volume":"50","author":"Brown","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clae.2022.101723_b0170","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1364\/BOE.4.002795","article-title":"Automatic segmentation of choroidal thickness in optical coherence tomography","volume":"4","author":"Alonso-Caneiro","year":"2013","journal-title":"Biomed Opt Express"},{"key":"10.1016\/j.clae.2022.101723_b0175","doi-asserted-by":"crossref","unstructured":"Lau JK, Cheung SW, Collins MJ, Cho P. Repeatability of choroidal thickness measurements with Spectralis OCT images. BMJ open ophthalmology 2019; 4: e000237.","DOI":"10.1136\/bmjophth-2018-000237"},{"key":"10.1016\/j.clae.2022.101723_b0180","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12886-022-02294-1","article-title":"Factors associated with faster axial elongation after orthokeratology treatment","volume":"22","author":"Qi","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.clae.2022.101723_b0185","doi-asserted-by":"crossref","unstructured":"Wang B, Naidu RK, Qu X. Factors related to axial length elongation and myopia progression in orthokeratology practice. PLoS One 2017;12:e0175913.","DOI":"10.1371\/journal.pone.0175913"},{"key":"10.1016\/j.clae.2022.101723_b0190","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.ophtha.2020.12.036","article-title":"Age Effect on Treatment Responses to 0.05%, 0.025%, and 0.01% Atropine: Low-Concentration Atropine for Myopia Progression Study","volume":"128","author":"Li","year":"2021","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.clae.2022.101723_b0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-88719-1","article-title":"Risk factors for rapid axial length elongation with low concentration atropine for myopia control","volume":"11","author":"Fu","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.clae.2022.101723_b0200","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/opo.12774","article-title":"Repeatability of pupil size measurements with NIDEK OPD-Scan III in myopic children","volume":"41","author":"Tan","year":"2021","journal-title":"Ophthalmic Physiol Opt"},{"issue":"3","key":"10.1016\/j.clae.2022.101723_b0205","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1444-0938.2006.00029.x","article-title":"Repeatability and agreement of two A-scan ultrasonic biometers and IOLMaster in non-orthokeratology subjects and post-orthokeratology children","volume":"89","author":"Chan","year":"2006","journal-title":"Clin Exp Optom"},{"issue":"2","key":"10.1016\/j.clae.2022.101723_b0210","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","article-title":"The multifunctional choroid","volume":"29","author":"Nickla","year":"2010","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"10.1016\/j.clae.2022.101723_b0215","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.neuron.2004.08.008","article-title":"Homeostasis of eye growth and the question of myopia","volume":"43","author":"Wallman","year":"2004","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.clae.2022.101723_b0220","article-title":"The effect of topical atropine on the choroidal thickness of healthy children","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.clae.2022.101723_b0225","doi-asserted-by":"crossref","first-page":"18310","DOI":"10.1038\/s41598-020-75342-9","article-title":"Additive effect of atropine eye drops and short-term retinal defocus on choroidal thickness in children with myopia","volume":"10","author":"Chiang","year":"2020","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.clae.2022.101723_b0230","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/OPX.0000000000000894","article-title":"Effects of orthokeratology on choroidal thickness and axial Length","volume":"93","author":"Chen","year":"2016","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.clae.2022.101723_b0235","doi-asserted-by":"crossref","unstructured":"Li Z, Hu Y, Cui D, Long W, He M, Yang X. Change in subfoveal choroidal thickness secondary to orthokeratology and its cessation: a predictor for the change in axial length. Acta Ophthalmol 2019; 97: e454-9.","DOI":"10.1111\/aos.13866"},{"key":"10.1016\/j.clae.2022.101723_b0240","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1364\/JOSAA.24.000578","article-title":"Three-dimensional relationship between high-order root-mean-square wavefront error, pupil diameter, and aging","volume":"24","author":"Applegate","year":"2007","journal-title":"J Opt Soc Am A Opt Image Sci Vis"},{"key":"10.1016\/j.clae.2022.101723_b0245","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/OPX.0b013e318033555e","article-title":"Potential higher-order aberration cues for sphero-cylindrical refractive error development","volume":"84","author":"Buehren","year":"2007","journal-title":"Optom Vis Sci"}],"container-title":["Contact Lens and Anterior Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048422001680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048422001680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T01:20:00Z","timestamp":1761268800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367048422001680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1367048422001680"],"URL":"https:\/\/doi.org\/10.1016\/j.clae.2022.101723","relation":{},"ISSN":["1367-0484"],"issn-type":[{"value":"1367-0484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Contact Lens and Anterior Eye","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clae.2022.101723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of British Contact Lens Association.","name":"copyright","label":"Copyright"}],"article-number":"101723"}}